From the Journals

Could tackling maternal obesity prevent later CVD in offspring?


 

FROM ATHEROSCLEROSIS


“Raised leptin levels, secreted by the adipose tissue, inhibit the in vitro proliferation of smooth muscle cells and could impede the angiogenesis process in vivo, but this assumption needs scientific validation in humans,” they said in their review.

However, human studies are lacking, aside from the epidemiologic reports that “cannot be used to confirm or contradict” the fetal programming hypothesis, they said.

Meanwhile, an increasing body of evidence has suggested that stressors in critical periods of fetal development may lead to epigenetic alterations that could play a role in either up-regulating atherogenic genes or down-regulating enzymatic activities that guard against oxidative stress.

For example, cohort studies have shown differences in DNA methylation among offspring born before and after bariatric surgery in the mother, which has lent credence to the hypothesis that maternal obesity in pregnancy alters methylation patterns for those offspring, Ms. Van De Maele and her colleagues wrote.

Lifestyle changes in obese pregnant women may have an effect on adverse metabolic or cardiovascular outcomes in offspring, although results to date are inconclusive, they added.

Diet, exercise, or both during pregnancy may lower the risk of macrosomia, respiratory distress syndrome, or other neonatal outcomes, particularly in high-risk women, according to the conclusions of a 2015 Cochrane review that Ms. Van De Maele and her coauthors cited.

However, follow-up studies on offspring are scarce and have shown no clear effects on long-term metabolic profiles in offspring, likely because of insufficient follow-up time, they said in their review.

Ms. Van De Maele and her coauthors said they had no conflict of interest disclosures related to their manuscript.

SOURCE: Van De Maele K et al. Atherosclerosis. 2018 Jun. doi: 10.1016/j.atherosclerosis.2018.06.016.

Pages

Recommended Reading

Adding hypertension in pregnancy doesn’t refine ASCVD risk prediction tool
MDedge Cardiology
MDedge Daily News: Why most heart failure may be preventable
MDedge Cardiology
Higher preconception blood pressure linked to pregnancy loss
MDedge Cardiology
Statins, ACE inhibitors linked to fetal cardiac anomalies
MDedge Cardiology
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Cardiology
Maternal morbidity and BMI: A dose-response relationship
MDedge Cardiology
MDedge Daily News: How to handle opioid constipation
MDedge Cardiology
Babies exposed to SSRIs in utero have decreased LV size
MDedge Cardiology
CARPREG II fine-tunes assessment of cardiac complication risk in pregnancy
MDedge Cardiology
How congenital heart disease affects brain development
MDedge Cardiology